Apyx Medical Corp reports results for the quarter ended June 30 - Earnings Summary

Apyx Medical

08/08/2025 04:13

Apyx Medical Corp APYX.OQ reported a quarterly adjusted loss of 9 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -19 cents.  The mean expectation of three analysts for the quarter was for a loss of 9 cents per share. Wall Street expected results to range from -10 cents to -8 cents per share.

Revenue fell 6.4% to $11.37 million from a year ago; analysts expected $11.70 million.

Apyx Medical Corp's reported EPS for the quarter was a loss of 9 cents​.

The company reported a quarterly loss of $3.78 million.

Apyx Medical Corp shares had fallen by 9.3% this quarter and gained 29.1% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 3.5% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is  "buy."

Wall Street's median 12-month price target for Apyx Medical Corp is $4.00, about 51% above its last closing price of $1.96

This summary was machine generated from LSEG data August 8 at 03:13 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Jun. 30 2025
-0.09
-0.09
Met
Mar. 31 2025
-0.12
-0.10
Beat
Dec. 31 2024
-0.16
-0.12
Beat
Sep. 30 2024
-0.19
-0.14
Beat